glp-1/fgf21 agonist boehringer Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases Fibroblast growth factor-21 is required
Pay in 4 interest-free payments of $6.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17



























